Andra AP-fonden’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.27M | Buy |
+4,232
| New | +$3.24M | 0.04% | 314 |
|
|
2025
Q3 | – | Sell |
-3,000
| Closed | -$1.57M | – | 484 |
|
|
2025
Q2 | $1.57M | Sell |
3,000
-18,500
| -86% | -$10.3M | 0.02% | 368 |
|
|
2025
Q1 | $13.6M | Sell |
21,500
-11,700
| -35% | -$8.05M | 0.22% | 163 |
|
|
2024
Q4 | $23.6M | Buy |
33,200
+6,900
| +26% | +$5.79M | 0.38% | 81 |
|
|
2024
Q3 | $27.6M | Sell |
26,300
-17,100
| -39% | -$19M | 0.41% | 74 |
|
|
2024
Q2 | $45.6M | Buy |
43,400
+16,900
| +64% | +$16.4M | 0.77% | 16 |
|
|
2024
Q1 | $25.5M | Buy |
26,500
+12,900
| +95% | +$12.3M | 0.45% | 71 |
|
|
2023
Q4 | $11.9M | Buy |
13,600
+6,800
| +100% | +$5.6M | 0.63% | 46 |
|
|
2023
Q3 | $5.6M | Sell |
6,800
-3,500
| -34% | -$2.75M | 0.33% | 145 |
|
|
2023
Q2 | $7.4M | Buy |
10,300
+400
| +4% | +$308K | 0.19% | 234 |
|
|
2023
Q1 | $8.13M | Sell |
9,900
-800
| -7% | -$603K | 0.21% | 194 |
|
|
2022
Q4 | $7.72M | Buy |
10,700
+2,400
| +29% | +$1.77M | 0.23% | 150 |
|
|
2022
Q3 | $5.72M | Sell |
8,300
-2,300
| -22% | -$1.45M | 0.19% | 242 |
|
|
2022
Q2 | $6.27M | Buy |
+10,600
| New | +$6.89M | 0.18% | 247 |
|
|
2021
Q4 | $6.25M | Buy |
9,900
+1,900
| +24% | +$1.17M | 0.13% | 364 |
|
|
2021
Q3 | $4.84M | Buy |
8,000
+1,300
| +19% | +$807K | 0.1% | 429 |
|
|
2021
Q2 | $3.74M | Buy |
+6,700
| New | +$3.39M | 0.08% | 499 |
|
|
2021
Q1 | – | Sell |
-5,600
| Closed | -$2.71M | – | 598 |
|
|
2020
Q4 | $2.71M | Sell |
5,600
-8,800
| -61% | -$4.75M | 0.06% | 538 |
|
|
2020
Q3 | $8.06M | Sell |
14,400
-1,500
| -9% | -$910K | 0.22% | 135 |
|
|
2020
Q2 | $9.92M | Sell |
15,900
-700
| -4% | -$397K | 0.29% | 20 |
|
|
2020
Q1 | $8.11M | Buy |
16,600
+4,700
| +39% | +$1.94M | 0.29% | 16 |
|
|
2019
Q4 | $4.47M | Sell |
11,900
-1,200
| -9% | -$404K | 0.13% | 442 |
|
|
2019
Q3 | $3.63M | Sell |
13,100
-2,000
| -13% | -$592K | 0.11% | 495 |
|
|
2019
Q2 | $4.73M | Buy |
15,100
+500
| +3% | +$166K | 0.14% | 395 |
|
|
2019
Q1 | $6M | Buy |
+14,600
| New | +$6.01M | 0.17% | 248 |
|
|
2018
Q3 | $5.21M | Sell |
12,900
-2,300
| -15% | -$875K | 0.13% | 380 |
|
|
2018
Q2 | $5.24M | Buy |
15,200
+6,000
| +65% | +$1.88M | 0.14% | 358 |
|
|
2018
Q1 | $3.17M | Buy |
9,200
+3,800
| +70% | +$1.32M | 0.08% | 566 |
|
|
2017
Q4 | $2.03M | Buy |
5,400
+3,200
| +145% | +$1.3M | 0.05% | 569 |
|
|
2017
Q3 | $984K | Buy |
2,200
+1,200
| +120% | +$571K | 0.02% | 638 |
|
|
2017
Q2 | $491K | Buy |
1,000
+100
| +11% | +$43.8K | 0.01% | 657 |
|
|
2017
Q1 | $349 | Hold |
900
| – | – | 0.01% | 634 |
|
|
2016
Q4 | $330K | Hold |
900
| – | – | 0.01% | 637 |
|
|
2016
Q3 | $362K | Sell |
900
-3,600
| -80% | -$1.44M | 0.01% | 594 |
|
|
2016
Q2 | $1.57M | Sell |
4,500
-900
| -17% | -$347K | 0.04% | 569 |
|
|
2016
Q1 | $1.95M | Hold |
5,400
| – | – | 0.05% | 528 |
|
|
2015
Q4 | $2.93M | Sell |
5,400
-100
| -2% | -$54.2K | 0.08% | 364 |
|
|
2015
Q3 | $2.56M | Buy |
5,500
+500
| +10% | +$269K | 0.07% | 412 |
|
|
2015
Q2 | $2.55M | Sell |
5,000
-800
| -14% | -$390K | 0.07% | 403 |
|
|
2015
Q1 | $2.62M | Sell |
5,800
-1,300
| -18% | -$551K | 0.07% | 398 |
|
|
2014
Q4 | $2.91M | Buy |
7,100
+3,000
| +73% | +$1.18M | 0.07% | 398 |
|
|
2014
Q3 | $1.48M | Sell |
4,100
-600
| -13% | -$201K | 0.03% | 477 |
|
|
2014
Q2 | $1.33M | Sell |
4,700
-11,900
| -72% | -$3.53M | 0.03% | 477 |
|
|
2014
Q1 | $4.99M | Sell |
16,600
-6,200
| -27% | -$1.91M | 0.12% | 299 |
|
|
2013
Q4 | $6.28M | Buy |
22,800
+1,500
| +7% | +$431K | 0.15% | 238 |
|
|
2013
Q3 | $6.66M | Buy |
21,300
+400
| +2% | +$105K | 0.17% | 208 |
|
|
2013
Q2 | $4.7M | Buy |
+20,900
| New | +$4.87M | 0.12% | 285 |
|
Other funds holding REGN
VCM
N
Andra AP-fonden's REGN Position: Q1 2026 in Review
Andra AP-fonden opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 4,232 shares worth $3.27M. The stake represents 0.04% of the portfolio and ranks #314 among its holdings. This is a return to the name: Andra AP-fonden previously reported a position in REGN as recently as Q2 2025.
Andra AP-fonden first reported a position in REGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $45.6M in Q2 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Andra AP-fonden held 4,232 shares of Regeneron Pharmaceuticals worth $3.27M as of Q1 2026.
- Regeneron Pharmaceuticals was a new Andra AP-fonden position in Q1 2026.
- Regeneron Pharmaceuticals made up 0.04% of Andra AP-fonden's portfolio in Q1 2026, its #314 holding.
- Andra AP-fonden first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
- Andra AP-fonden's Regeneron Pharmaceuticals position peaked at $45.6M in Q2 2024.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.